Litcius/Paper detail

Clinical Experience with Ropeginterferon Alfa-2b in the Off-Label Use for the Treatment of COVID-19 Patients in Taiwan

Kuan-Yuan Chen, Kang‐Yun Lee, Albert Qin, Ching-Shan Luo, Yun‐Kai Yeh, Jing‐Quan Zheng, Ching-Mei Chen, Chan‐Yen Tsai, Sheena Lin, Jason J. Z. Liao, Yi‐Wen Huang, Po‐Hao Feng

2021Advances in Therapy10 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineCoronavirus disease 2019 (COVID-19)GastroenterologyDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchRespiratory viral infections research
Clinical Experience with Ropeginterferon Alfa-2b in the Off-Label Use for the Treatment of COVID-19 Patients in Taiwan | Litcius